These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prenatal screening of congenital heart disease between ethics and cost-effectiveness. Time for a change in current prenatal ultrasound screening policies? Paladini D Ultrasound Obstet Gynecol; 1999 Oct; 14(4):225-8. PubMed ID: 10586471 [No Abstract] [Full Text] [Related]
5. Routine ultrasound in early pregnancy. Anderson T Pract Midwife; 1998 Dec; 1(12):13-4. PubMed ID: 10214284 [No Abstract] [Full Text] [Related]
6. Cost-effectiveness of one-stage ultrasound screening in pregnancy: a report from the Helsinki ultrasound trial. Leivo T; Tuominen R; Saari-Kemppainen A; Ylöstalo P; Karjalainen O; Heinonen OP Ultrasound Obstet Gynecol; 1996 May; 7(5):309-14. PubMed ID: 8774094 [TBL] [Abstract][Full Text] [Related]
7. [Current developments in preventive health care]. Pajkrt E; Bilardo CM Ned Tijdschr Geneeskd; 1997 Dec; 141(50):2470. PubMed ID: 9555134 [No Abstract] [Full Text] [Related]
9. Modelling of decision analysis and costs. Durand-Zaleski I; Chaix C Eur Radiol; 1998; 8(3):491-3. PubMed ID: 9510595 [No Abstract] [Full Text] [Related]
10. [Decision of the Federal Joint Committee on screening for chorionicity - benefit assessment in the absence of screening studies]. Schwalm A; Bertelsmann H; Gruber S; Wietschel G; Matthias K Gesundheitswesen; 2013 Jan; 75(1):13-21. PubMed ID: 22847814 [TBL] [Abstract][Full Text] [Related]
11. The Routine Antenatal Diagnostic Imaging with Ultrasound Study: another perspective. DeVore GR Obstet Gynecol; 1994 Oct; 84(4):622-6. PubMed ID: 8090403 [TBL] [Abstract][Full Text] [Related]
12. Cost of routine ultrasonography. Gunderson EW Am J Obstet Gynecol; 1994 Aug; 171(2):581-2. PubMed ID: 8059857 [No Abstract] [Full Text] [Related]
13. Routine fetal ultrasound: a billion dollar baby? Bieze J Diagn Imaging (San Franc); 1994 Mar; 16(3):65-74. PubMed ID: 10146688 [No Abstract] [Full Text] [Related]
14. Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis. Caughey AB; Kuppermann M; Norton ME; Washington AE Am J Obstet Gynecol; 2002 Nov; 187(5):1239-45. PubMed ID: 12439512 [TBL] [Abstract][Full Text] [Related]
15. Fetal Down syndrome screening: a cost effectiveness analysis of alternative screening programs. Cusick W; Vintzileos AM J Matern Fetal Med; 1999; 8(6):243-8. PubMed ID: 10582856 [TBL] [Abstract][Full Text] [Related]
16. Routine second-trimester ultrasonography in the United States: a cost-benefit analysis. Vintzileos AM; Ananth CV; Smulian JC; Beazoglou T; Knuppel RA Am J Obstet Gynecol; 2000 Mar; 182(3):655-60. PubMed ID: 10739525 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia. Ortved D; Hawkins TL; Johnson JA; Hyett J; Metcalfe A Ultrasound Obstet Gynecol; 2019 Feb; 53(2):239-244. PubMed ID: 29700870 [TBL] [Abstract][Full Text] [Related]
18. On the value of the RADIUS (routine antenatal diagnostic imaging with ultrasound) study. Taylor WS Am J Obstet Gynecol; 1995 May; 172(5):1641-2. PubMed ID: 7755088 [No Abstract] [Full Text] [Related]